Cargando…

Change in Eosinophil Count in Patients with Heart Failure Treated with Anakinra

Background: Interleukin-1 blockade with anakinra leads to a transient increase in eosinophil blood count (eosinophils) in patients with acute myocardial infarction. We aimed to investigate the effect of anakinra on changes in eosinophils in patients with heart failure (HF) and their correlation with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golino, Michele, Moroni, Francesco, Del Buono, Marco Giuseppe, Canada, Justin M., Talasaz, Azita H., Piñel, Sebastian, Mbualungu, James, Vecchiè, Alessandra, Ho, Ai-Chen (Jane), Thomas, Georgia K., Carbone, Salvatore, Billingsley, Hayley E., Turlington, Jeremy, Markley, Roshanak, Trankle, Cory, De Ponti, Roberto, Van Tassell, Benjamin, Abbate, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137267/ https://www.ncbi.nlm.nih.gov/pubmed/37190038 http://dx.doi.org/10.3390/cells12081129

Ejemplares similares

Differential Response to Interleukin‐1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction
por: Golino, Michele, et al.
Publicado: (2023)

Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction
por: Del Buono, Marco Giuseppe, et al.
Publicado: (2022)

Interleukin‐1 blockade in heart failure: an on‐treatment and off‐treatment cardiorespiratory fitness analysis
por: Moroni, Francesco, et al.
Publicado: (2023)

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure
por: Wohlford, George F., et al.
Publicado: (2021)

3426 Increased Monounsaturated Fat Consumption is Associated with Improved Body Composition in Subjects with Obesity and Heart Failure with Preserved Ejection Fraction
por: Billingsley, Hayley, et al.
Publicado: (2019)

Abnormal left ventricular subendocardial perfusion and diastolic function in women with obesity and heart failure and preserved ejection fraction
por: Markley, Roshanak, et al.
Publicado: (2023)

Low NT‐proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction
por: Buckley, Leo F., et al.
Publicado: (2018)

Increased C-reactive protein is associated with the severity of thoracic radiotherapy-induced cardiomyopathy
por: Canada, Justin M., et al.
Publicado: (2020)

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study
por: Van Tassell, Benjamin, et al.
Publicado: (2022)

3415 Percent Predicted Peak Exercise Oxygen Pulse Is a Marker of Cardiac Reserve Following Thoracic Radiotherapy
por: Canada, Justin McNair, et al.
Publicado: (2019)

Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity and HFpEF: The UFA-Preserved Pilot Study
por: Carbone, Salvatore, et al.
Publicado: (2019)

The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA‐HF study
por: Carbone, Salvatore, et al.
Publicado: (2020)

C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction
por: van Wezenbeek, Jessie, et al.
Publicado: (2018)

2363: Ventriculo-arterial coupling and left ventricular mechanical work in systolic and diastolic heart failure
por: Buckley, Leo, et al.
Publicado: (2018)

Edema Index Predicts Cardiorespiratory Fitness in Patients With Heart Failure With Reduced Ejection Fraction and Type 2 Diabetes Mellitus
por: Marawan, Amr, et al.
Publicado: (2021)

Impaired myocardial relaxation with exercise determines peak aerobic exercise capacity in heart failure with preserved ejection fraction
por: Trankle, Cory, et al.
Publicado: (2017)

Myocarditis after RNA-based COVID-19 vaccines: Where do we stand?
por: Moroni, Francesco, et al.
Publicado: (2022)

Dietary Fat, Sugar Consumption, and Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction
por: Carbone, Salvatore, et al.
Publicado: (2017)

Orthostatic intolerance syndromes after hematopoietic cell transplantation: clinical characteristics and therapeutic interventions in a single-center experience
por: Vecchié, Alessandra, et al.
Publicado: (2021)

2544: Dietary polyunsaturated fatty acid consumption is associated with improved body composition in nonalcoholic steatohepatitis patients
por: Billingsley, Hayley, et al.
Publicado: (2018)

Interleukin‐1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST‐Segment–Elevation Myocardial Infarction
por: Abbate, Antonio, et al.
Publicado: (2020)

Metabolic modulation predicts heart failure tests performance
por: Contaifer, Daniel, et al.
Publicado: (2019)

2390: Cardiac abnormalities drive exercise intolerance in patients with nonslcoholic fatty liver disease
por: Canada, Justin M., et al.
Publicado: (2018)

Acute Effects of Liothyronine Administration on Cardiovascular System and Energy Metabolism in Healthy Volunteers
por: Chen, Shanshan, et al.
Publicado: (2022)

Lifestyle Interventions with a Focus on Nutritional Strategies to Increase Cardiorespiratory Fitness in Chronic Obstructive Pulmonary Disease, Heart Failure, Obesity, Sarcopenia, and Frailty
por: Billingsley, Hayley E., et al.
Publicado: (2019)

277 Heart Failure Clinical Trial Enrollment at a Rural Satellite Hospital
por: Abbate, Antonio, et al.
Publicado: (2022)

Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction: Still Awaiting Translation
por: Trankle, Cory, et al.
Publicado: (2016)

Influence of extracellular volume fraction on peak exercise oxygen pulse following thoracic radiotherapy
por: Canada, Justin M., et al.
Publicado: (2022)

Obesity paradox in cardiovascular disease: where do we stand?
por: Carbone, Salvatore, et al.
Publicado: (2019)

2438: Dose-dependent nature of cocaine infusions on cardiovascular hemodynamics
por: Carbone, Salvatore, et al.
Publicado: (2018)

Physical activity, sedentary behaviors and all-cause mortality in patients with heart failure: Findings from the NHANES 2007–2014
por: Kim, Youngdeok, et al.
Publicado: (2022)

Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective
por: Talasaz, Azita Hajhossein, et al.
Publicado: (2020)

Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease
por: Vecchié, Alessandra, et al.
Publicado: (2021)

The Potential Role of Clinical Pharmacy Services in Patients with Cardiovascular Diseases
por: Talasaz, Azita Hajhossein
Publicado: (2012)

Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up
por: Dixon, Dave L, et al.
Publicado: (2017)

The antioxidant potential of the Mediterranean diet in patients at high cardiovascular risk: an in-depth review of the PREDIMED
por: Billingsley, Hayley E, et al.
Publicado: (2018)

Anakinra for patients with COVID-19
por: Maoujoud, Omar, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Valette, Xavier, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Martin-Silva, Nicolas, et al.
Publicado: (2020)

Effect of anakinra in COVID-19
por: Kooistra, Emma J, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_br6j2abhet42g5f0nrj160j74u